Illuccix and PSMA Imaging for the Initial Staging of Prostate Cancer

The presentation focuses on Gallium 68-PSMA-11 (Illuccix) PET/CT imaging for Initial Staging of Prostate Cancer, Biochemical Recurrence and for the selection of patients for whom Lu177-PSMA-617 is indicated. Dr. Naveen Kella is board certified in urology, with a fellowship in Urologic Oncology and robotic surgery. He is known for his experience in treating prostate cancer and has performed over 2,500 robotic prostate cancer surgeries. Dr. Kella is also an Adjunct Assistant Professor for the UT Health Science Center. The presentation will include case studies illustrating the clinical utility of Illuccix for urology patients and provide an understanding of the mode of action for Illuccix and the radiographic PET/CT findings in prostate cancer.

Naveen Kella, MD

o Founder of The Urology Place, Dr. Kella is board certified in urology, with a fellowship in Urologic Oncology and robotic surgery. He is known for his experience in treating prostate cancer and has performed over 2,500 robotic prostate cancer surgeries. Literature notes the best surgeons usually have a superior experience. Dr. Kella is the most experienced robotic prostate surgeon in San Antonio and South Texas. In fact, he is one of the most experienced in the nation. Dr. Kella is also an Adjunct Assistant Professor for the UT Health Science Center.

AUANewsWorthy Webinar Opening Slides - Telix

Duration

00:00:32

Event Details